Automated external defibrillator maker Defibtech agrees to be acquired by Japanese medical device company Nihon Kohden.
But unlike Asahi Kasei, the diversified chemical manufacturer that dropped $2.2 billion on Zoll Medical Corp. in April, Nihon Kohden is a pure-play medical device company.
"Defibtech will not only continue expanding its AED product lineup, but also plans to develop and market other resuscitation solutions," CEO Dr. Glenn Laub said in prepared remarks. "Over the past decade, having deployed more than 160,000 AEDs worldwide, we are a steadily growing force in the resuscitation market. We want to continue that growth."